US 9034318
Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
granted A61KA61K31/198A61K31/205
Quick answer
US patent 9034318 (Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/198, A61K31/205, A61K31/385, A61K38/51